chrisvoncsefalvay/vaers-outcomes huggingface dataset:
pt recvd vax & exp severe & unrelenting vomiting;ER or MD visit was required;sx subsided;
Vaccination 4/19/16. On 4/20 c/o pain/swelling rt. shoulder area, no SOB/sx. No numbness, weakness. 4/21 - unscheduled visit to Dr. - Increased rt. shoulder pain, swelling decreased ROM rt. shoulder - MEDROL DOSE PAK given 4/24/16 - Called, arm improved.
Information has been received from a physician concerning a 2 month old female who on 12-FEB-2007 was vaccinated with a 2ml oral dose of Rotateq (lot #115F). Concomitant vaccination administered that day included a dose of Comvax, Prevnar and Dtap. The patient "may have had" blood in stool at the time of vaccination. On 12-FEB-2007 the patient developed hematochezia. A lab test was performed to verify if there was blood in stool, the results were not reported. Subsequently, the patient recovered. The patient's hematochezia was considered to be an other important medical event. Additional information has been requested.
swelling, redness area of inj;hot to touch;inc to peak spread size of softball by 3rd day p/inj;minor itch;all sx gone in 7 days;
No additional AEs; MMR II was mixed with lidocaine and administered; This spontaneous report was received from a physician referring to a patient of unknown age. Information regarding the patient's concurrent conditions, medical history, historical drugs and concomitant therapies was not provided.     On 13-APR-2022, the patient was vaccinated with measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II) lot # T018892, expiration date 02-JUN-2022, at a dose of 0.5 milliliter, subcutaneous for prophylaxis. The vaccine had been mixed with lidocaine previous to administration (product preparation issue).  No other information provided. No additional adverse events or product quality complaints (PQC) reported.
first night, chilled, heavy blanketing and slight headache. second day, headaches, fatigued, achy, nauseous. slept most of day.  night heavy sweat out - wet tshirt, bedding. third day - continued headache, but feeling better.
Lip swelled after shots in Feb. and March. Over the last month have had extensive itching over entire body, more so behind knees, inner thighs, feet, hands. It wasn't until my lip swelled after the shot in March that I correlated it. Some of the itching was also accompanied with welts. Itching on inner thighs was worst after the March shot.
Patient received the Heplisav vaccine first dose on 2/16/22. Patient's father called 3 hours later and stated pt was unable to see, and after looking up the Hepatitis B vaccine he saw that this was a side effect. RN did verify that sudden blindness was a side effect. RN instructed father to take pt to the ER immediately so that steroids may be given. MD notified. RN tried calling pt and father on the following day and was unable to reach either, message was left. Pt did come on his next day 2/18/22 and states he did go to the ER but continues to be unable to see.  Adverse event completed.
Area erythematous with swelling, c/o nausea, wheezing, abdominal pain, fever. Area erythematous by swelling growing larger, painful, itchy. 9/10/07 Pt in for reeval today f/u CBC normal. Swelling has enlarged. CHN provided w/Merck NSC #1 encouraged MD to call and also review package insert - reaction should not preclude f/up dose.
Three days after administration of vaccine developed redness/swelling/itching which progressed from shoulder to elbow.
Patient became light headed and lost consciousness for a few seconds.  Regained consciousness without assist of smelling salts. Blood pressure was low and Heart Rate was bradycardic at initial measurement. Patient was provided with oral fluids and monitored for 45 minutes.  Patient was discharged after his vital signs became more stable and  he was able to walk about unassisted and without complaints of dizziness.
I was fine for about 10 hours after the vaccine. Then started with sleeplessness, traveling pain in my joints, hip, neck, and back. That pain persisted for 24 hours. The pain all over my body and in my joints resolved, but I started with an intense stabbing pain that started in my lower back any time I'd bend over or extend my torso. The pain traveled up my back until the evening when it settled between my shoulder blades and the base of my neck. The next day, my back and neck were stiff and painful. I called the doctor and he said it was likely that the spine was inflamed and should go away by day 5. The pain receded, but last night I noticed a very distended and bloated belly. I'm petite and it is not usual for me. I now also have a mental fog that is concerning me. When driving carpool for my son's soccer practice (a route I do ever week), I made several wrong turns and only was made aware I was going in the right direction when the kids told me. I still have stiffness in my neck and back and a headache. None of these symptoms did I experience before the second vaccine shot.
Patient stated she previously received the Moderna COVID-19 vaccine and had a severe reaction consisting of tinnitus. She also stated she discussed the side effect with her PCP, and would like to receive the Pfizer COVID-19 vaccine to complete her vaccine series.
Heavy bruising & soreness - I've been getting flu shots yearly for most of my life and NEVER had it do that. It held the bruising discoloration for over a month and even a health care provider saw it and wondered where I got such an awful bruise. I told her it was from my flu shot. She was appalled that it was given so high on my arm.
Mom brought pt in on 7-21-10 to have immunization site checked. Pt received immunizations on 7-19-10. Mom said it started swelling yesterday. (L) D is swollen, red and warm to touch. Pt said it itches and is tender. Inst mom to put ice or cool cloth to area and use BENADRYL po or cream AD.
CHILLS, NAUSEA, HEAD ACHE, STOMACH ACHE, TEMP 100.P, SLIGHT SORE THROAT.
Vaccine triggered IBS symptoms; This is a spontaneous report from a contactable consumer, the patient. A 26-year-old non-pregnant female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; lot number: en6206), via unspecified route of administration in left arm on 18Mar2021 at 9:30 (at the age of 26-year-old at vaccination) as a single dose for COVID-19 immunisation. Medical history included IBS (irritable bowel syndrome). The patient had no allergies to medications, food or other products. Concomitant medications included ADDERAL, CLARITIN, LOESTRIN Fe, PROBIO and VITAMIN D (MANUFACTURER UNKNOWN); all for an unknown indication started since unknown date and unknown if ongoing. Prior to vaccination, the patient was not diagnosed with COVID-19. Since vaccination, the patient was not tested for COVID-19. On 18Mar2021 at 11:00, the vaccine triggered irritable bowel syndrome for the patient. The patient experienced diarrhoea an hour post injection and it was following every two hours. No therapeutic measures were taken for the events. The clinical outcome of the event irritable bowel syndrome aggravated was not resolved at the time of this report. No further information is expected. No follow-up is possible.
majority of the liquid came out while administering the vaccine due to syringe failure; majority of the liquid came out while administering the vaccine due to syringe failure; This spontaneous case was reported by a consumer and describes the occurrence of DEVICE CONNECTION ISSUE (majority of the liquid came out while administering the vaccine due to syringe failure) and UNDERDOSE (majority of the liquid came out while administering the vaccine due to syringe failure) in a 38-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 022B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 22-May-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-May-2021, the patient experienced DEVICE CONNECTION ISSUE (majority of the liquid came out while administering the vaccine due to syringe failure) and UNDERDOSE (majority of the liquid came out while administering the vaccine due to syringe failure). At the time of the report, DEVICE CONNECTION ISSUE (majority of the liquid came out while administering the vaccine due to syringe failure) and UNDERDOSE (majority of the liquid came out while administering the vaccine due to syringe failure) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       It was reported that patient would like to know what she is supposed to do now. Patient had called on behalf of a vaccine administrator. Lot#022B21A (not sure if it was first or second dose)
Breakthrough case admission after 4 vaccines Moderna 1/29/21 Lot# 027L20A;  Moderna 2/25/21 Lot#010M20A;  Moderna 11/12/21 Lot# 018F21A;  Moderna 6/4/22 Lot# 037A22b
Vaccine administered to left shoulder joint; A spontaneous report was received from a consumer concerning a 44-year old, male patient who received Moderna's COVID-19 Vaccine (mRNA-1273) and experienced vaccine administered to left shoulder joint.  The patient's medical history was not provided. No relevant concomitant medications were reported.   On 13 Jan 2021, approximately 0 days prior to the onset of the event, the patient received his first dose of mRNA-1273 (Lot number 012L20A)  for prophylaxis of COVID-19 infection.  On 13 Jan 2021, the patient noticed the site of the injection was more on his shoulder joint rather than the upper arm. No treatment information was provided.  Action taken with mRNA-1273 in response to the event was not reported.  The event, vaccine administered to left shoulder joint, was considered resolved on 13 Jan 2021.; Reporter's Comments: This case concerns concerning a 44-year old, male patient who received his first dose of mRNA-1273 (Lot number 012L20A) for prophylaxis of COVID-19 infection and the patient noticed the site of the injection was more on his shoulder joint rather than the upper arm. There were no reported adverse events associated with the event of product administered at inappropriate site.
hives-nothing x/hives; isolated to face & upper lt cheekbone-upper lt arm;
patient states "feels foggy" and dizzy starting 2 days post vaccine, still ongoing 4 days post vaccine
Area around right eye twitching; right arm weakness.; right arm pain.; This is a spontaneous report from a contactable consumer, the patient. A 32-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8730) via an unspecified route of administration in the left arm on 05Apr2021 at 12:00(at the age of 32-years-old) as a single dose for COVID-19 immunisation. Medical history included chronic migraine and exercise induced asthma. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Concomitant medications included ibuprofen (ADVIL), taken for an unknown indication from an unknown start date and unknown if ongoing. Patient had no known allergies to food, medication or other products. On 07Apr2021 at 00:00, the patient experienced twitching in the area around right eye and right arm weakness/pain. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events twitching in the area around right eye and right arm weakness/pain was not resolved at the time of this report.   No follow-up attempts are needed. No further information is expected.
Diagnosed with Bells Palsy by a clinic within 4 weeks of receiving a J&J vaccine. Symptoms resolved prior to 3/8/2022 when I interviewed patient. I did not treat him for Bells Palsy, however, so I do not have complete records of the onset of symptoms, etc.
I came home after getting the vaccine and I felt a little bit different but after that I was ok. In the beginning of June it just hit me. I could not understand what happened. My hip and leg gave up on me. I could hardly walk. I had a bunch of mucus in my chest. I was taking different antibiotics to get it together. I am almost cleared up but I still have the wheezing every now and then. I had to go to an urgent care clinic for the stuff in my chest. They did x-rays for my hip and MRI. They said with the MRI my cartilage is gone. At the end of July I went to the doctor because the z-pak did not work, and then the amoxicillin did not work either. They gave me Amoxicillin Clavulanate and that has been helping.
pt recvd 3NOV95 & 5NOV95 pt devel a chicken pox like rash on face, chest, scalp, & legs; MD reported that there were around 30-50 total lesions;pt subsequently recovered;
Received  Meningococcal B Vaccine on 7/20/22 , IM in right arm and a few hours later right arm begin to get red,itching ,swelling and hot to the touch with a knot noted at injection site, all of these signs went away except the knot at the IM site and occasional itching at the site which she still has today on 8/9/2022.
Pain in left arm and swelling per ED record (patient presented to ED, two days after administration).
12/28 received COVID-19 vaccine left deltoid.  This was complicated with momentary (about 30 sec)  lightheaded and some pruritis, although patient continued with work (rounding on service).  Self treated with tylenol.  She noted two spots on her left arm (pictures emailed to me), self-treated with motrin.  12/29 in the arm she believed the spots on her left wrist were more pronounced, with new spots on her forearm. Round maculopapular back left of spine 12/19 in am.  Self treated with claritin.  Called the reaction line and evaluated by Dr. on Thursday as all symptoms progressed.  Simmered down over the weekend.  Last claritin or any antihistamine was 6 days ago.     Had COVID with positive PCR in April 2019.  Still with positive antibodies, measured repeatedly as part of participation in program.  Persistent loss of taste and smell.   No history of known miralex exposure.  Has not had a colonoscopy before.  Minimal use of personal care products/lotions.   Received annual flu vaccine without complications.  Never history of anaphylaxis.  Allergic reaction to COVID19 vaccine with diffuse cutaneous symptoms; not classical IgE mediated reaction No evidence of clear anaphylaxis to COVID-19 vaccine (or any other injectable).  Patient received their second dose of vaccine on 1/19 - 30 minutes of monitoring instead of 15 minutes.
Swollen Lips after 2nd dose; Rash all over the body which is red, swollen, comes and does on different parts of body; Rash all over the body which is red and swollen; Rash all over the body; This spontaneous case was reported by a consumer and describes the occurrence of LIP SWELLING (Swollen Lips after 2nd dose), RASH ERYTHEMATOUS (Rash all over the body which is red, swollen, comes and does on different parts of body), SWELLING (Rash all over the body which is red and swollen) and RASH (Rash all over the body) in a 68-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 024M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 11-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Feb-2021, the patient experienced LIP SWELLING (Swollen Lips after 2nd dose), RASH ERYTHEMATOUS (Rash all over the body which is red, swollen, comes and does on different parts of body), SWELLING (Rash all over the body which is red and swollen) and RASH (Rash all over the body). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) for Adverse event, at a dose of 1 dosage form; PARACETAMOL (TYLENOL) for Adverse event, at a dose of 1 dosage form and FEXOFENADINE HYDROCHLORIDE (ALLEGRA) for Adverse event, at a dose of 1 dosage form. On 14-Feb-2021, LIP SWELLING (Swollen Lips after 2nd dose) had resolved. On 03-Mar-2021, RASH ERYTHEMATOUS (Rash all over the body which is red, swollen, comes and does on different parts of body), SWELLING (Rash all over the body which is red and swollen) and RASH (Rash all over the body) had resolved. Not Provided      mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged.       Patient reported that treatment with Allegra was not helping    This case was linked to US-MODERNATX, INC.-MOD-2021-074816 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-074816:First dose case
Case number PHEH2014US022013, is an initial spontaneous report received from a health care professional (materials manager) on 31 Oct 2014. This report refers to a 35 years old female patient. Her medical history and concomitant medications were not reported. She was vaccinated with FLUVIRIN (batch number: 1412501) at a dose of 0.5 ml intramuscularly in the arm on 10 Oct 2014. It was reported that on an unknown date, she experienced sore and tender arms at the vaccination site. She complained that her arm hurt so much that she could not lift it. The event outcome was unknown. The seriousness and causality were not reported.
neck ache & stiff 3 days;sore spot in middle of chest, h/a for 3 days; APAP given
This spontaneous report was received from a 66 years old unidentified female laboratory worker via company representative, the female refers to herself. There was no information about the patient's concurrent conditions, concomitant therapies or medical history provided. On an unknown date, the patient was vaccinated with ZOSTAVAX for prevention of shingles(dose, route and site of administration, lot # and expiration date were not reported).        The lab worker stated that shortly after receiving the ZOSTAVAX injection, she developed "one zoster-like bump on her forehead". On an unknown date, she saw her physician (unspecified physician) who stated that the bump was "a shingles bump". The physician also stated that, "it was good that the lab worker received the ZOSTAVAX injection", or it might have been, full-blown shingles. The lab worker stated that any other issues not occurred. The outcome of the event and the relatedness between the event and ZOSTAVAX were not reported. Additional information is not expected due to lack of the reporter's contact details.
pt reported hot & sweaty flashes 31MAR93 weakness/dizziness usually p/eating; denies diarrhea or vomiting; unsure of reaction p/1st 2 shots; poss stress related;
Diffuse hives and erythematous rash on arms, neck and chest.  She had expected fever and muscle aches for 24 hours after vaccine administration but this resolved.
Diarrhea, loose stool q2h, starting 4 days after the vaccine, now on day 3 of diarrhea. Has diaper rash. No dehydration. No vomiting. No blood
Received 2nd Dose 5 Months After Receiving First Dose; Initial Report Received on 25-Jul-2023    A personal assistant and registered x-ray technologist reported that a 54-year-old female (race and ethnicity not provided), received the second dose of HEPLISAV-B (hepatitis B vaccine) for hepatitis B immunization five months after receiving the first dose.     No medical history, allergies, or concomitant medications at the time of vaccination were reported.    On 01-Feb-2023, the patient received the first dose of HEPLISAV-B (Lot # 941591; expiration date, NDC?#, route, and injection site not reported).    One 23-Jun-2023, almost 5 months (143 days) after having been vaccinated with the first dose of HEPLISAV-B, the patient received the second dose of HEPLISAV-B (Lot # 941060; expiration date, NDC?#, route, and injection site not reported).  Both doses were administered at a clinic. No adverse reactions were reported.    No additional information was provided.   Company Comment: The company assessed the event as non-serious.; Sender's Comments: The company assessed the event as non-serious.
Information has been received from a physician concerning a male patient who was vaccinated with MMRII..Subsequently 7-10 days after immunization, the patient experienced idoipathic thrombocytopenic purpura. It was noted that he never went for his second dose. Upon internal review, the patient's thrombocytopenic purpura was considered to be an Other Important Medical Event. FOLLOW-UP Information was received and indicated that the patient had recovered from the experience. No further information is available.
On 5/8 I developed pain in my neck and half my face was feeling strange. I woke up and didn't have feeling in the right half of my face. I went to urgent care on 5/9 and was dx'd w/ Bell's Palsy and was given an anti-viral and prednisone. On 5/13, I went to a physical therapists.
Daughter had second shot of GARDASIL and is having bad headaches, pain in the abdomen, nausea, night sweats, depression, lower back pain.  Her first shot she vomited once, but no other side effects.  2/12/09 Office note received from PCP dated 12/17/08 for 16 yr WCC. Normal exam. Assessment:  Well Adolescent.  Possible pregnancy (due to LMP 2 months ago-normally irregular) Pt not seen for OV since 12/17/08.  Only in for vax 2/3/09. No further info available.
Pain around injection site on the left arm one week after covid vaccine, with shingles developing at the same time on the left side of my neck chest and neck.
Rash on neck; This is a spontaneous report received from a contactable consumer. This 50-year-old female consumer reported for herself that she received the first dose of BNT162B2 (Pfizer-BioNTech COVID-19 Vaccine; Solution for Injection; lot number: Unknown) via an unspecified route of administration in the left arm on 25Mar2021 at 09:45AM as a single dose for COVID-19 immunization. The patient was allergic to Pollen. The patient did not receive any other vaccine within 2 weeks and 4 weeks prior to the vaccine. The patient did not undergo COVID test post vaccination. On 25Mar2021, the patient experienced rash on neck. The patient did not receive any treatment for rash on neck. The clinical out for the event rash on neck was captured as Not recovered.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
(R) arm injection site numbness. (-) weakness of arm. Had mild swelling improved now. Rest of the arm no numbness.
January 5th I was having severe body aches high fever cough and sore throat, I went to urgent care and was diagnosed with covid , symptoms lasted 8 days total.
Pain at site in injection arm followed by increasing redness, warmth,  swelling and hardness surrounding injection site
Client c/o diaphoresis, facial flushing and headache. Student went to ER where she received Benadryl and was monitored. Student returned to school.
Missed Dose for the second administration; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (Missed Dose for the second administration) in a 33-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 03-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (Missed Dose for the second administration). At the time of the report, PRODUCT DOSE OMISSION ISSUE (Missed Dose for the second administration) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication details was reported. No treatment medication details was reported.